Racial/Ethnic Differences in Receipt of Timely Adjuvant Therapy for Older Women with Breast Cancer: Are Delays Influenced by the Hospitals Where Patients Obtain Surgical Care?

Authors


Address correspondence to Rachel A. Freedman, M.D., M.P.H., Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215; e-mail: Rachel_Freedman@dfci.harvard.edu.

Abstract

Objective

To examine whether hospitals where patients obtain care explain racial/ethnic differences in treatment delay.

Data Source

Surveillance, Epidemiology, and End Results data linked with Medicare claims.

Study Design

We examined delays in adjuvant chemotherapy or radiation for women diagnosed with stage I–III breast cancer during 1992–2007. We used multivariable logistic regression to assess the probability of delay by race/ethnicity and included hospital fixed effects to assess whether hospitals explained disparities.

Principal Findings

Among 54,592 women, black (11.9 percent) and Hispanic (9.9 percent) women had more delays than whites (7.8 percent, p < .0001). After adjustment, black (vs. white) women had higher odds of delay (odds ratio = 1.25, 95 percent confidence interval = 1.10–1.42), attenuated somewhat by including hospital fixed effects (OR = 1.17, 95 percent CI = 1.02–1.33).

Conclusions

Hospitals are the important contributors to racial disparities in treatment delay.

Ancillary